You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

CLINICAL TRIALS PROFILE FOR MENOPUR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for MENOPUR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00257556 ↗ A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa Completed Ferring Pharmaceuticals Phase 4 2005-10-01 Prospective open label, randomised, parallel group, comparative pilot.
NCT00335894 ↗ Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF). Completed IBSA Institut Biochimique SA Phase 3 2005-05-01 Multicenter, prospective, randomized, investigator blind, controlled clinical trial. Two parallel groups, one receiving the test drug hMG (hMG-IBSA, IBSA Institut Biochimique sa) and the other the reference drug hMG (Menopur, Ferring Pharmaceuticals, Inc.).
NCT00492934 ↗ What is the Best Preparation for Embryo Transfer in Cryo Cycles: a Natural Cycle or Light Hormonal Stimulation? Unknown status University Hospital, Gasthuisberg N/A 2004-01-01 The study investigates if, among women with a regular cycle (between 25 and 45 days), the endometrium is better prepared for the transfer of an embryo that was cryopreserved and if the subsequent embryo implantation rate is higher when the cycle is started with daily, small-dose hormonal injections than in cycles without these daily injections.
NCT00802360 ↗ MENOPUR® Versus FOLLISTIM® Completed Ferring Pharmaceuticals Phase 4 2008-12-01 To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for MENOPUR

Condition Name

Condition Name for MENOPUR
Intervention Trials
Infertility 24
Infertility, Female 6
Subfertility 2
Fertility 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for MENOPUR
Intervention Trials
Infertility 34
Infertility, Female 8
Polycystic Ovary Syndrome 2
Menopause, Premature 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MENOPUR

Trials by Country

Trials by Country for MENOPUR
Location Trials
United States 56
Spain 8
Belgium 5
Denmark 5
France 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for MENOPUR
Location Trials
Illinois 5
Texas 5
Florida 5
Colorado 4
California 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MENOPUR

Clinical Trial Phase

Clinical Trial Phase for MENOPUR
Clinical Trial Phase Trials
Phase 4 14
Phase 3 10
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for MENOPUR
Clinical Trial Phase Trials
Completed 29
Unknown status 6
Recruiting 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MENOPUR

Sponsor Name

Sponsor Name for MENOPUR
Sponsor Trials
Ferring Pharmaceuticals 14
IBSA Institut Biochimique SA 3
Hospital de Clinicas de Porto Alegre 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for MENOPUR
Sponsor Trials
Other 28
Industry 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.